Seralutinib

Seralutinib · GB002, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Seralutinib, covering 2026-02-09 to 2026-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) [Phase 3]